Cite

HARVARD Citation

    Teachey, D. et al. (2022). Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. Journal of clinical oncology. 40 (19), pp. 2106-2118. [Online]. 
  
Back to record